Table 2.
Parameter | Subject Group |
|
Controls (n = 18) | Patients (n = 18) | |
Gender (M/F) | 12/6 | 13/5 |
Race (C/AA) | 16/2 | 16/2 |
Age (y) | 42.4 (7.8) | 43.7 (7.9) |
Hollingshead Index | 3.4 (1.0) | 2.9 (1.4) |
Premorbid verbal IQ | 111.5 (10.0) | 106.2 (11.8) |
CPZ equivalent | — | 465.7 (436.7) |
Duration of illness (y) | — | 16.9 (11.8) |
PANSS negative (total) | — | 14.7 (4.2) |
PANSS positive (total) | — | 15.3 (7.2) |
Note: SDs are shown in parenthesis. M = male, F = female, C = Caucasian, AA = African American, CPZ = chlorpromazine, PANSS = Positive and Negative Syndrome Scale.81